Are Wall Street Analysts Predicting Kenvue Stock Will Climb or Sink?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 02 2025
0mins
Should l Buy C?
Source: NASDAQ.COM
Company Overview: Kenvue Inc., a consumer health company with a market cap of $46 billion, offers popular brands like Tylenol and Neutrogena, and has outperformed the S&P 500 Index over the past year, with shares rising 27.1%.
Recent Performance and Outlook: After a Q4 earnings report showing a revenue decline and lower adjusted EPS, analysts maintain a "Moderate Buy" rating for KVUE, with expectations for flat EPS growth in fiscal 2025 and a price target suggesting potential upside.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy C?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on C
Wall Street analysts forecast C stock price to rise
18 Analyst Rating
15 Buy
3 Hold
0 Sell
Strong Buy
Current: 107.270
Low
87.00
Averages
131.00
High
150.00
Current: 107.270
Low
87.00
Averages
131.00
High
150.00
About C
Citigroup Inc. is a global diversified financial services holding company. The Company’s segments include Services, Markets, Banking, Wealth and U.S. Personal Banking (USPB). The Services segment includes Treasury and Trade Solutions (TTS) and securities services. TTS provides an integrated suite of tailored cash management, trade and working capital solutions to multinational corporations, financial institutions and public sector organizations. The Markets segment provides corporate, institutional and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products and commodities. The Banking segment includes investment banking, which supports client capital-raising needs to help strengthen and grow their businesses. The Wealth segment includes Private Bank, Wealth at Work and Citigold and provides financial services to a range of client segments. USPB segment includes branded cards and retail services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Price Target Adjustment: Citi has reduced its price target for Micron Technology from $510 to $425, primarily due to a 6% decline in mainstream DDR5 DRAM prices since the company's quarterly results on March 18, which directly impacts market expectations.
- Price Pressure Factors: The bank highlighted that Google's TurboQuant compression technique has exerted pressure on spot prices, resulting in a roughly 19% decline in Micron's stock since Google detailed the method in a research blog post on March 24, reflecting market concerns about future price trends.
- Long-Term Contract Negotiations: Analysts noted that memory suppliers are negotiating multiyear agreements with hyperscale customers to lock in base volumes and prepayments, with such contracts potentially including quarterly pricing adjustments that could support contract prices and enhance market stability.
- Growth in Compute Demand: TurboQuant reduces the memory footprint of AI models through quantization techniques, and Citi believes that these efficiency gains could ultimately increase overall compute demand, similar to the market response seen after DeepSeek's earlier breakthrough, indicating the potential driving force of technological advancements in the industry.
See More
- Market Turmoil Impact: The ongoing U.S.-Iran conflict has caused concern among investors, leading to a nearly 8% drop in the S&P 500 in March, marking its worst monthly performance since 2022.
- Citi Analyst Strategy: Citi analyst Richard Schlatter sought stocks that could sidestep recent volatility by overlaying crowding composites tracked by Citi, identifying stocks with positive catalysts that are not relatively crowded, aiming for a favorable reaction to fundamental tailwinds.
- Delta Air Lines Outlook: Delta Air Lines' stock has only dropped 3.8% this month, despite a nearly 9% decline in 2026, with Wall Street expecting a rebound; the average analyst price target from LSEG suggests a potential 25% gain over the next year.
- Summit Therapeutics Performance: Summit Therapeutics' stock has risen 2.4% since the war began, with a long crowding composite of just 18.1%, and analysts are generally bullish, as 13 out of 18 covering analysts rate it a buy or strong buy.
See More
- Market Pullback: The S&P 500 has pulled back 7% year-to-date, with AI stocks like Microsoft and Palantir down 26% and nearly 20%, respectively, indicating a market reassessment of these high-valuation stocks that may dampen investor confidence in the short term.
- Investor Sentiment Shift: Despite the AI sector facing a reality check similar to the dot-com bubble of 2000, the strong demand for AI solutions suggests that this pullback could be short-lived, presenting a potential entry point for investors.
- Optimistic Earnings Projections: Analysts expect Nvidia to report earnings of $8.27 per share for the current fiscal year, a 74% increase year-over-year, while Microsoft's revenue growth is projected to exceed 16%, indicating that despite high valuations, future profit potential remains robust.
- Market Repricing Process: Many analysts believe the current price adjustments are more of a
See More
- Market Pullback Analysis: The S&P 500 has seen a 7% year-to-date decline as AI stocks are perceived as liabilities, with Microsoft down 26% from last year-end, indicating heightened investor concerns over high valuations that may lead to short-term market volatility.
- Optimistic Earnings Projections: Despite facing a price reset, analysts expect Nvidia to report earnings of $8.27 per share for the current fiscal year, a 74% increase year-over-year, suggesting that the market remains optimistic about the profitability of the AI sector, potentially attracting more investor interest.
- Improved Industry Fundamentals: Unlike the dot-com bubble of the late 1990s, current AI companies possess real cash flows and stronger fundamentals, allowing them to remain stable during adjustments and reducing investment risks.
- Emerging Investment Opportunities: Although enthusiasm for AI stocks has waned, the long-term outlook remains positive as the market gains a clearer understanding of these companies' profit potential, presenting savvy investors with opportunities to identify undervalued investments.
See More
- UBS Upgrade: UBS upgrades Adecoagro from Neutral to Buy, raising the price target from $8 to $16.2, indicating the company is poised to benefit from the ongoing Middle East conflict, which is expected to enhance its financial performance.
- HSBC Bullish on Carnival: HSBC upgrades Carnival from Hold to Buy, asserting that the current share price undervalues the resilience of experience-led demand, which is likely to improve the company's market performance in the near future.
- Morgan Stanley Reiterates Meta: Morgan Stanley lowers its price target for Meta from $825 to $775 but maintains it as a top investment idea, suggesting that market sentiment has bottomed out, making it an opportune time to buy.
- Deutsche Bank Upgrades Colgate: Deutsche Bank upgrades Colgate-Palmolive from Hold to Buy, highlighting the company's core business as having long-term investment value and the ability to weather current market volatility effectively.
See More
- Memory Chip Industry Growth: Micron Technology holds a significant position in the memory chip industry, and despite its stock being 23% below its high, the company reported nearly tripled revenue last quarter due to strong demand from data centers, highlighting its critical role in AI infrastructure development.
- Optimistic Earnings Forecast: Analysts expect Micron's adjusted earnings to grow 13% annually through fiscal 2029, making the current valuation of 16 times adjusted earnings reasonable, with a median target price of $550 per share implying a 56% upside from the current price of $352.
- Ad Tech Innovation: AppLovin's stock is 48% below its high, yet its newly launched self-service platform provides robust advertising technology support for e-commerce, with the CEO stating it serves as the foundation for the next decade of growth, showcasing the company's leading position in AI innovation.
- Undervalued Market Position: Despite facing short-term challenges, AppLovin's earnings are projected to increase by 44% annually through 2027, with the current valuation of 38 times earnings considered cheap; the median target price among 32 analysts is $650 per share, indicating a 71% upside from its current price of $380.
See More











